CHLORAMBUCIL, FLUDARABINE PHOSPHATE, Lisaftoclax, ACALABRUTINIB, Lisaftoclax, Lisaftoclax, RITUXIMAB, CYCLOPHOSPHAMIDE MONOHYDRATE, RITUXIMAB
APG2575CC301
Phase 3 small_molecule active
Quick answer
CHLORAMBUCIL, FLUDARABINE PHOSPHATE, Lisaftoclax, ACALABRUTINIB, Lisaftoclax, Lisaftoclax, RITUXIMAB, CYCLOPHOSPHAMIDE MONOHYDRATE, RITUXIMAB for Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active